23.04.2007
opracowanie na podstawie: High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L.L. Villa, R.L.R. Costa, C.A. Petta, R.P. Andrade, J. Paavonen, O.-E. Iversen, S.-E. Olsson, J. H?ye, M. Steinwall, G. Riis-Johannessen, A. Andersson-Ellstrom, K. Elfgren, G. von Krogh, M. Lehtinen, C. Malm, G.M. Tamms, K. Giacoletti, L. Lupinacci, R. Railkar, F.J. Taddeo, J. Bryan, M.T. Esser, H.L. Sings, A.J. Saah, E. Barr
British Journal of Cancer, 2006; 95: 1459–1466
